Alnylam Pharmaceuticals, Inc. (ALNY)
232.89
-6.11
(-2.56%)
USD |
NASDAQ |
Aug 27, 13:02
Alnylam Pharmaceuticals 1 Year Total Returns (Daily) : -47.03% for Aug. 26, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 26, 2026 | -47.03% |
| August 25, 2026 | -45.88% |
| August 24, 2026 | -48.06% |
| August 21, 2026 | -49.48% |
| August 20, 2026 | -49.97% |
| August 19, 2026 | -47.06% |
| August 18, 2026 | -49.96% |
| August 17, 2026 | -49.97% |
| August 14, 2026 | -48.35% |
| August 13, 2026 | -47.49% |
| August 12, 2026 | -47.91% |
| August 11, 2026 | -49.15% |
| August 10, 2026 | -50.57% |
| August 07, 2026 | -49.62% |
| August 06, 2026 | -49.52% |
| August 05, 2026 | -45.40% |
| August 04, 2026 | -47.80% |
| August 03, 2026 | -45.16% |
| July 31, 2026 | -47.60% |
| July 30, 2026 | -39.53% |
| July 29, 2026 | -13.29% |
| July 28, 2026 | -11.20% |
| July 27, 2026 | -15.33% |
| July 24, 2026 | -17.14% |
| July 23, 2026 | -17.47% |
| Date | Value |
|---|---|
| July 22, 2026 | -17.92% |
| July 21, 2026 | -15.33% |
| July 20, 2026 | -14.93% |
| July 17, 2026 | -17.62% |
| July 16, 2026 | -12.29% |
| July 15, 2026 | -10.28% |
| July 14, 2026 | -10.92% |
| July 13, 2026 | -8.54% |
| July 10, 2026 | -7.40% |
| July 09, 2026 | -2.52% |
| July 08, 2026 | 1.89% |
| July 07, 2026 | -0.78% |
| July 06, 2026 | -5.69% |
| July 02, 2026 | -5.15% |
| July 01, 2026 | -6.33% |
| June 30, 2026 | -7.68% |
| June 29, 2026 | -9.08% |
| June 26, 2026 | -8.45% |
| June 25, 2026 | -8.94% |
| June 24, 2026 | -9.52% |
| June 23, 2026 | -7.97% |
| June 22, 2026 | -7.52% |
| June 18, 2026 | -10.96% |
| June 17, 2026 | -8.42% |
| June 16, 2026 | -8.71% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Ionis Pharmaceuticals, Inc. | 50.25% |
| Regeneron Pharmaceuticals, Inc. | 39.35% |
| Vertex Pharmaceuticals, Inc. | 41.35% |
| BridgeBio Pharma, Inc. | 62.41% |
| Pfizer Inc. | 21.56% |